Find and Pitch Jounalists, Get Your Story Covered

Tags: Software & Services Software Platforms IT Automation Apple cell biology, Craniofacial, developmental biology, DNA repair, genetics, oxidative stress

	Profile	Recent Articles on Subject
1	Michael Gibney Pharma Voice Teacher of English. Teacher of politics. Santiago, Chile educationpolitics	Cancer vaccines have stumbled, but the approach is gaining new steam - about 1 month ago Regeneron’s R&D approach scores dual wins against Alexion’s Ultomiris and in lymphoma - 4 months ago What is a ‘cure,’ really? AbbVie’s Humira creator leaps into the next phase of medicine - 5 months ago As new Alzheimer’s biomarkers come into play, here’s where the money is going - 6 months ago Huntington’s disease R&D is regaining ground after several disappointments - 7 months ago Will the IRA squash new drugs? Those worries are likely exaggerated, studies say. - 7 months ago Now a biopharma powerhouse, Vertex’s R&D bedrock could deliver tomorrow’s blockbusters - 11 months ago Big hopes for schizophrenia treatment rely on a deep pipeline of new approaches - about 1 year ago The roadblocks faced by Biogen are many, but execs point to an R&D-focused turnaround - about 1 year ago
2	Kathryn Palmer Inside Higher Ed General assignment reporter at Inside Higher Ed. Tempe, Arizona general reportinghigher education	Ending the Research 1 ‘Arms Race’ - about 2 months ago
3	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	As financial headwinds pick up, pharmas are aiming to squeeze more ROI from their R&D - about 2 months ago PharmaVoice’s Crystal Ball: The industry’s AI future - 3 months ago What’s next for 23andMe? - 4 months ago 2024 PharmaVoice 100s: Trailblazers - 6 months ago Neuro drugs are still faltering, despite rising investment - 8 months ago Pharma’s R&D gamble: picking pipeline winners in a risky field - 10 months ago Neurvati touts fresh, ‘synergistic’ investment model in neuroscience R&D - about 1 year ago Astellas’ science chief on the leap into new technologies - about 1 year ago PharmaVoice’s Crystal Ball: What’s next in drug innovation and clinical trials - about 1 year ago PharmaVoice 100s: Clinical trial gurus - over 1 year ago
4	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Merck is broadening its pipeline as Keytruda’s patent cliff looms - 3 months ago Oncology, obesity and more: Where pharma R&D is headed in 2025 - 4 months ago 2024 PharmaVoice 100s: Clinical Trial Pros - 5 months ago The hunt for the brain’s biomarkers - 10 months ago FDA’s platform designation aims to ease R&D pain points - 10 months ago 4 offbeat biotechs making a splash in the life sciences - 11 months ago As antimicrobial resistance looms large, a nonprofit teams up with Big Pharma to intervene - about 1 year ago Pharma CFOs need R&D vigilance in tough economic times - about 1 year ago
5	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	AI set to revolutionise pharmaceutical R&D says GlobalData - 3 months ago Years and years - about 1 year ago
6	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Tuberculosis R&D funding is up, but still short of goals and dominated by a few players, report finds - 4 months ago STAT+: Pharmalittle: We’re reading about Moderna R&D cuts, Lilly plant investments and more - 7 months ago
7	Adam Spatacco Motley Fool Community for top investors. Investingcommunity	This is Huge News For Eli Lilly Investors - 6 months ago
8	Matthew Herper STAT News Writes at STAT. Biology's century. Undisclosed biologydatajournalism	STAT+: Moderna touts research progress as it cuts R&D spending by $1.1 billion - 7 months ago STAT+: J&J to emphasize cancer drugs and stop much of its vaccine research - over 1 year ago
9	Jason Mast STAT News Writing about science, medicine. ScienceMedicineBusiness	STAT+: Moderna touts research progress as it cuts R&D spending by $1.1 billion - 7 months ago
10	Stewart Burnett Automotive World Voice of the remarketing & used car sectors. remarketingautomotive industry	Research Cooperation: BMW Group and University of Zagreb Optimize Battery Cell Production with Artificial Intelligence - 7 months ago

Journalists covering Research & Development